Back to top
more

Glaukos (GKOS)

(Delayed Data from NYSE)

$141.75 USD

141.75
681,591

+2.42 (1.74%)

Updated Nov 8, 2024 04:00 PM ET

After-Market: $141.98 +0.23 (0.16%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value D Growth A Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 25% (63 out of 250)

Industry: Medical - Instruments

Zacks News

Integer (ITGR) Beats Earnings and Revenue Estimates in Q4

Integer Holdings (ITGR) reported adjusted earnings of 87 cents per share in the fourth quarter of 2016, lower than the year-ago quarter figure of 92 cents.

    Amedisys (AMED) Earnings Top Q4 Estimates, Revenues Lag

    Amedisys Inc. (AMED) reported adjusted earnings from continuing operations of 44 cents per share in the fourth quarter of 2016, up 10% year over year.

      Medtronic (MDT) Presents 5-Year Cost Data of CRT Devices

      Medtronic plc (MDT) recently presented a five-year data report on cardiac resynchronization therapy (CRT) devices within its Cardiac Rhythm & Heart Failure (CRHF) division.

        Allscripts Launches Clinical Pathways for Cancer Treatment

        Allscripts Healthcare Solutions, Inc. (MDRX) recently announced the launch of Clinical Pathways program for the treatment of cancer.

          MedTech Stocks' Q4 Earnings on Mar 1: ICUI, GKOS & EGRX

          Let's take a look at the major MedTech stocks within the broader medical community, slated to release their reports on Mar 1.

            VWR Corporation (VWR) Tops Earnings in Q4; View Dull

            VWR Corporation (VWR) reported fourth-quarter 2016 adjusted earnings per share (EPS) of 45 cents, reflecting a 4.3% decline from the year-ago quarter.

              Integra (IART) Posts In-Line Q4 Earnings, Issues 2017 View

              Integra LifeSciences Holdings Corporation (IART) reported adjusted earnings per share of 52 cents in the fourth quarter of 2016, up 18% from the year-ago adjusted number.

                Medtronic Poised on Strong Fundamentals Despite Several Woes

                On Feb 23, we issued an updated research report on medical device major, Medtronic plc (MDT).

                  Omnicell: Q4 Report Disappoints, Aesynt Buyout Holds Promise

                  On Feb 22, we issued an updated research report on Mountain View, CA-based Omnicell Inc. (OMCL).

                    Patterson Companies (PDCO) Earnings Beat Estimates in Q3

                    Patterson Companies Inc. (PDCO) reported third-quarter fiscal 2017 adjusted earnings of 58 cents per share from continuing operations, which came higher than the Zacks Consensus Estimate of 57 cents.

                      Fresenius Medical (FMS) Tops Earnings in Q4, View Upbeat

                      Fresenius Medical Care AG & Co. KGAA (FMS) reported adjusted earnings of 63 cents per American Depositary Share (ADS) in the fourth quarter of 2016, beating the Zacks Consensus Estimate of 61 cents.

                        Inovalon (INOV) Q4 Earnings In Line, Revenue Beat Estimates

                        Inovalon Holdings, Inc. (INOV) reported fourth-quarter 2016 adjusted earnings of 2 cents per share, which came in line with the Zacks Consensus Estimate.

                          Align Expands Internationally with Dental Couture Buyout

                          Align Technology (ALGN) has recently announced the acquisition of Dubai, UAE and Nicosia, Cyprus-based distributor, G.L. Dental Couture Limited.

                            Teleflex (TFX) Gains FDA Approval for TrapLiner Catheter

                            Teleflex Incorporated (TFX) recently announced 510(k) clearance for its TrapLiner Catheter from the US FDA for a full fledged commercial launch in the country.

                              Henry Schein Inks Agreement for Rijuven's CardioSleeve

                              Henry Schein, Inc. (HSIC) recently signed an exclusive distribution agreement with patient care platform designer Rijuven Corp. to sell the latter's CardioSleeve device

                                Wright Medical (WMGI) Posts Narrower-than-Expected Q4 Loss

                                Wright Medical Group N.V. (WMGI) reported adjusted loss of 6 cents per share in the fourth quarter of 2016, narrower than loss of 8 cents reported in the year-ago quarter and the Zacks Consensus Estimate of a loss of 11 cents.

                                  DaVita (DVA) Ties Up with Cigna Arm, Expands in Los Angeles

                                  DaVita HealthCare Partners Inc. (DVA), a leading provider of dialysis services, announced that HealthCare Partners, a unit within its medical group, has entered into a strategic partnership with Cigna, a global health insurance service company.

                                    Henry Schein (HSIC) Tops Q4 Earnings, Reaffirms '17 View

                                    Henry Schein, Inc. (HSIC) reported adjusted earnings per share of $1.88 in the fourth quarter of 2016, up 12.6% year over year and surpassed the Zacks Consensus Estimate by 2.2%.

                                      Ecolab's (ECL) Earnings, Revenues Miss Estimates in Q4

                                      Ecolab Inc. (ECL) reported fourth-quarter 2016 adjusted earnings of $1.25 per share, which missed the Zacks Consensus Estimate of $1.27.

                                        Medtronic (MDT) Beats on Q3 Earnings, Retains Sales View

                                        Medtronic plc'S (MDT) third-quarter fiscal 2017 Adjusted earnings per share (EPS) came in at $1.12, a penny ahead of the Zacks Consensus Estimate.

                                          Henry Schein to Acquire SAS to Strengthen Dental Offerings

                                          Henry Schein Inc. (HSIC) announced its decision to acquire Southern Anesthesia + Surgical (SAS).

                                            DENTSPLY (XRAY) Beats on Earnings in Q4, Misses Revenues

                                            DENTSPLY SIRONA Inc. (XRAY) reported adjusted earnings per share of 67 cents in the fourth quarter of 2016, surpassing the Zacks Consensus Estimate by 2 cents.

                                              Zacks.com featured highlights: Xcerra, Glaukos, Nova Measuring Instruments, Customers Bancorp and DNB Financial

                                              Zacks.com featured highlights: Xcerra, Glaukos, Nova Measuring Instruments, Customers Bancorp and DNB Financial

                                                Allscripts (MDRX) Q4 Earnings Miss Estimates, View Upbeat

                                                Allscripts Healthcare Solutions, Inc.(MDRX) reported fourth-quarter 2016 earnings of 10 cents per share, which missed the Zacks Consensus Estimate by 2 cents.

                                                  DaVita (DVA) Earnings Beat Estimates, Revenues Lag in Q4

                                                  DaVita Inc. (DVA) reported fourth-quarter 2016 adjusted operating earnings of 98 cents per share that surpassed the Zacks Consensus Estimate of 91 cents.